IVABRADINE THERAPY IN PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
The combination of coronary heart disease (CHD) and chronic obstructive pulmonary disease (COPD) is widely prevalent in clinical practice. The problem of adequate therapy choice is important, since the majority of the medications administered in isolated CHD or COPD are contraindicated for the combi...
Saved in:
| Main Authors: | N. A. Zheleznyakova, I. M. Sokolov, E. Ya. Gafanovich |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2012-02-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/1196 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective If-channel inhibitor ivabradine in the treatment of sinus tachycardia in coronary heart disease patients with acute heart failure and inferior myocardial infarction
by: S. A. Sayganov, et al.
Published: (2010-06-01) -
Ivabradine – a new agent for coronary heart disease treatment
by: O. A. Maneshina, et al.
Published: (2006-06-01) -
ANTIISCHEMIC EFFECTIVENESS OF IVABRADINE AND ITS IMPACT ON MICROCIRCULATION IN PATIENTS WITH CORONARY HEART DISEASE ASSOCIATED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. A. Garganeeva, et al.
Published: (2012-08-01) -
IVABRADINE IN PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION: NEW DATA FROM THE SHIFT MULTICENTER RANDOMIZED TRIAL
by: S. N. Tereshchenko, et al.
Published: (2016-08-01) -
Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine
by: N. N. Kushnarenko, et al.
Published: (2020-08-01)